Finance

Lists
Why is MBRX down 5.42%?
Dive Deeper
MBRX:NASDAQ
Moleculin Biotech Inc
$0.57
-5.42%
(-0.033) 1D
$0.56
-0.70% (-0.0040)
Pre-market
Closed: Sep 28, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MBRX...
Open
$0.60
High
$0.60
Low
$0.54
Mkt. cap
11.63M
Avg. vol.
1.06M
Volume
5.21K
52-wk high
$15.75
52-wk low
$0.16
EPS
-$15.07
Beta
1.92
Shares outstanding
19.48M
No. of employees
17
Open
$0.60
High
$0.60
Low
$0.54
Mkt. cap
11.63M
Avg. vol.
1.06M
Volume
5.21K
52-wk high
$15.75
52-wk low
$0.16
EPS
-$15.07
Beta
1.92
Shares outstanding
19.48M
No. of employees
17
News stories
From web sources and news partners
About Moleculin Biotech Inc
CEO-
Employees17
Founded2015
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitemoleculin.com
Analyst ratings
Based on 3 analysts giving stock ratings to MBRX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MBRX in the last 3 months.
Highest
Current $0.57
$31.00 (+5,348.15%)
Average
$12.00 (+2,008.96%)
Lowest
$2.00 (+251.49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sara Nik
H.C. Wainwright
Buy
Maintained
$3.00
+427.2%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$2.00
+251.5%
08/17/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$31.00
+5,348.2%
08/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.74M
5.12M
5.38M
5.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.15M
2.41M
2.49M
2.10M
Operating expense
5.91M
7.53M
7.87M
7.56M
Total operating expenses
5.91M
7.53M
7.87M
7.56M
Operating income
-5.91M
-7.53M
-7.87M
-7.56M
Other non operating income
-19.53M
23.08M
-5.00M
4.00K
EBT including unusual items
-25.40M
15.55M
-12.84M
-7.64M
EBT excluding unusual items
-25.40M
15.55M
-12.84M
-7.64M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-25.40M
15.55M
-12.84M
-7.64M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
39.00K
9.00K
34.00K
-
Interest expense
-
-
-
-78.00K
Net interest expenses
39.00K
9.00K
34.00K
-78.00K
Depreciation and amortization charges
21.00K
9.00K
8.00K
8.00K
EBITDA
-5.88M
-7.52M
-7.87M
-7.55M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps